Mechanism of progestin resistance in endometrial precancer/cancer through Nrf2-AKR1C1 pathway.
about
Brusatol inhibits HIF-1 signaling pathway and suppresses glucose uptake under hypoxic conditions in HCT116 cells.Aldo-Keto Reductase AKR1C1-AKR1C4: Functions, Regulation, and Intervention for Anti-cancer Therapy.Mechanism of progestin resistance in endometrial precancer/cancer through Nrf2-survivin pathway.Nrf2: a potential therapeutic target for naturally occurring anticancer drugs?Progestin Intrauterine Devices and Metformin: Endometrial Hyperplasia and Early Stage Endometrial Cancer Medical Management.Nrf2 induces cisplatin resistance via suppressing the iron export related gene SLC40A1 in ovarian cancer cells.Nrf2 inhibition affects cell cycle progression during early mouse embryo development.Aldo-Keto Reductase Regulation by the Nrf2 System: Implications for Stress Response, Chemotherapy Drug Resistance, and Carcinogenesis.AKR1C1 Activates STAT3 to Promote the Metastasis of Non-Small Cell Lung Cancer.
P2860
Q37508566-0F272C24-F960-4AA4-9255-4247FD46B9AAQ37698258-013F60D0-A495-4511-9748-1BBDC13C8D65Q37733068-5469A892-098E-48EF-985A-99095120FB58Q38694717-7412701D-2C42-4BE2-92C0-86D0FC3B76A3Q41665625-5EC7FC81-5697-478E-89D8-61620D673F19Q47094256-56D33451-2958-4219-9549-DE2BFE060527Q47284033-88EA2E48-64A3-48DE-A168-3CFFC90AC776Q48251191-9F7E68F5-B5FB-4B77-907C-E0C074BC2DD4Q49416353-2BE5990B-7202-4656-B677-B4ACA63ADCF4
P2860
Mechanism of progestin resistance in endometrial precancer/cancer through Nrf2-AKR1C1 pathway.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Mechanism of progestin resista ...... r through Nrf2-AKR1C1 pathway.
@en
type
label
Mechanism of progestin resista ...... r through Nrf2-AKR1C1 pathway.
@en
prefLabel
Mechanism of progestin resista ...... r through Nrf2-AKR1C1 pathway.
@en
P2093
P2860
P356
P1433
P1476
Mechanism of progestin resista ...... r through Nrf2-AKR1C1 pathway.
@en
P2093
Donghui Guo
Donna Zhang
Ji-Young Park
Setsuko K Chambers
Wenxin Zheng
Xiaofang Yi
Yiying Wang
P2860
P304
10363-10372
P356
10.18632/ONCOTARGET.7004
P407
P577
2016-01-25T00:00:00Z